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Abstract
Background: By 2030, 30% of the European population will be aged 60 or over and those aged 80 and above will
be the fastest growing cohort. An increasing number of people will die at an advanced age with multiple chronic
diseases. In Europe at present, between 12 and 38% of the oldest people die in a long-term care facility. The lack of
nationally representative empirical data, either demographic or clinical, about people who die in long-term care
facilities makes appropriate policy responses more difficult. Additionally, there is a lack of comparable cross-country
data; the opportunity to compare and contrast data internationally would allow for a better understanding of both
common issues and country-specific challenges and could help generate hypotheses about different options
regarding policy, health care organization and provision. The objectives of this study are to describe the
demographic, facility stay and clinical characteristics of residents dying in long-term care facilities and the
differences between countries.
Methods: Epidemiological study (2015) in a proportionally stratified random sample of 322 facilities in Belgium,
Finland, Italy, the Netherlands, Poland and England. The final sample included 1384 deceased residents. The
sampled facilities received a letter introducing the project and asking for voluntary participation. Facility manager,
nursing staff member and treating physician completed structured questionnaires for all deaths in the preceding 3
months.
Results: Of 1384 residents the average age at death ranged from 81 (Poland) to 87 (Belgium, England) (p < 0.001)
and length of stay from 6months (Poland, Italy) to 2 years (Belgium) (p < 0.05); 47% (the Netherlands) to 74% (Italy)
had more than two morbidities and 60% (England) to 83% (Finland) dementia, with a significant difference
between countries (p < 0.001). Italy and Poland had the highest percentages with poor functional and cognitive
status 1 month before death (BANS-S score of 21.8 and 21.9 respectively). Clinical complications occurred often
during the final month (51.9% England, 66.4% Finland and Poland).
Conclusions: The population dying in long-term care facilities is complex, displaying multiple diseases with
cognitive and functional impairment and high levels of dementia. We recommend future policy should include
integration of high-quality palliative and dementia care.
Keywords: End-of-life care, Long-term care facility, Nursing homes, Palliative care, Policy
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: elisabeth.honinx@vub.be; nanjavandop@gmail.com
1Department of Family Medicine & Chronic Care, Vrije Universiteit Brussel
(VUB) & Ghent University, Laarbeeklaan 103, 1090 Brussels, Belgium
Full list of author information is available at the end of the article
Honinx et al. BMC Public Health         (2019) 19:1199 
https://doi.org/10.1186/s12889-019-7532-4
Background
By 2030, 30% of the European population will be aged
60 or over and those aged 80 and above will be the fast-
est growing cohort [1]. An increasing number of people
will die at an advanced age with multiple chronic dis-
eases [2–4]. In Europe at present, between 12 and 38%
of the oldest people die in a long-term care facility [5].
The term long-term care facility in this study is used for
all ‘collective institutional settings where care, on-site
provision of personal assistance with activities of daily
living, and on-site or off-site provision of nursing and
medical care, is provided for older people who live there
24 hours a day, 7 days a week, for an undefined period
of time’6 .There are many types of long-term care facil-
ities, due to the different health care systems and fund-
ing mechanisms in different countries [6]. Also, the
number of older people in need of high quality end-of-
life care in such facilities is increasing [2, 4]. Studies of
the complexity of challenges posed by people spending
their end-of-life period in long-term care facilities have
so far been small-scale and limited to specific regions or
illnesses [5–8].
The lack of nationally representative empirical data, ei-
ther demographic or clinical, about people who die in
long-term care facilities makes appropriate policy re-
sponses more difficult [7]. There are very few statistics
comparable across Europe on the prevalence of demen-
tia and multimorbidity, on functional and cognitive sta-
tus or on clinical complications at the end of life in the
residential setting. This lack of data makes it difficult for
policy and decision-makers to gain insight into the key
challenges of this population and provides them with
few opportunities to monitor changes over time. Add-
itionally, there is a lack of comparable cross-country
data; the opportunity to compare and contrast data
internationally would allow for a better understanding of
both common issues and country-specific challenges and
could help generate hypotheses about different options
regarding policy, health care organization and provision.
Palliative Care for Older People (PACE) is an EU-
funded project (2014–2019) which set out to conduct
comparative research on older people dying in long-term
care facilities in Europe. It is the first study aiming to de-
scribe and compare the characteristics of dying residents
across 6 European countries, Belgium, the Netherlands,
England, Finland, Italy and Poland. These countries were
selected to reflect a variety of health care systems and
geographic regions in Europe [9, 10].
The main research questions are [1]: what are the
demographic and facility-stay characteristics of people
who die in long-term care facilities and how do they dif-
fer between the 6 participating countries, and [2] what
are the clinical characteristics of the residents who die
there, including the prevalence of dementia and other
conditions, their functional and cognitive status 1 month
before death and the clinical complications during the
last month of life, and how do these differ between the 6
countries.
Methods
Study design
An epidemiological study of deceased residents in long-
term care facilities was conducted in Belgium, the
Netherlands, England, Finland, Italy and Poland in 2015
[9]. To obtain representative samples of facilities, a pro-
portional stratified random sampling procedure was
used within each country. Based on available national or
regional lists of all long-term care facilities, facilities
were randomly and proportionally selected from several
strata (based on at least region/province and facility size
by beds). In Belgium and the UK, a sample was drawn
from the region where most of the population lives
(Flanders and England respectively). In England, the na-
tionwide ENRICH (Enabling Research in Care Homes)
network was used to increase participation of facilities.
In Italy there was no public national list available and in-
stead a convenience sample was used based on a previ-
ously constructed cluster of facilities interested in
research, which covered the 3 macro regional areas and
took into account different sizes and types of facilities.
In each country, participating facilities reported every
death that occurred among the residents of their facility
over the preceding 3-month period. Deceased residents
were included in the study when death occurred in the
facility, as were those whose deaths were registered out-
side (e.g. in acute care hospitals).
More details about the study design and protocol have
been published [9].
Setting and participants
Several types of long-term care facilities can be distin-
guished within the 6 countries, depending on whether
care by specific health care professionals is provided on-
site or off-site (see Table 1) [6, 9]. Type 1 includes facil-
ities with 24 h care from on-site physicians, nurses and
care assistants, type 2 are facilities with 24 h care from
on-site nurses and care assistants and care from physi-
cians who are based off-site and type 3 consists of facil-
ities with 24 h on-site care from care assistants and care
from nurses and physicians who are based off-site.
For each identified deceased resident, structured ques-
tionnaires were sent to the facility administrator/man-
ager, the nursing staff member most involved in care
(preferably a nurse) and the treating physician (TP; a
general practitioner, elderly care physician or physician
employed in the facility). For each participating facility,
the administrator/manager was also asked to fill out a
questionnaire on facility characteristics.
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Data collection
The long-term care facilities that were sampled in each
country received a letter introducing the PACE project
and asking for voluntary participation. Additional con-
tact was made by phone or e-mail. Each participating fa-
cility appointed a contact person and was visited by a
researcher. During this visit, the contact person listed all
residents who had died in the preceding 3 months and
identified 3 key respondents for each deceased resident
(facility administrator/manager, nursing staff member,
treating physician and relative) with the use of a struc-
tured checklist. Questionnaires were sent to the key re-
spondents and up to 2 reminders were sent to non-
responders (after 3 and 6 weeks). To ensure high-quality
data collection, researchers in all countries were trained
to follow a quality assurance manual designed for this
project.
Measurements
After-death questionnaires included validated instru-
ments and were forward-backward translated according
to European Organisation for Research and Treatment
of Cancer guidelines [11] in cases where official transla-
tions did not exist.
The questionnaire for the facility administrator/man-
ager included questions about the resident’s age, sex,
residency before admission, length of stay, placement in
ward or unit for residents with dementia at the time of
death, place and cause of death, ownership (public,
private-nonprofit or private-profit) and size of the
facility.
The questionnaire for the nursing staff member in-
cluded questions about the presence of dementia at the
time death in the staff member’s opinion, the clinical
complications during the last month of life (pneumonia,
febrile episode, eating or drinking problem, hip fracture,
stroke, gastrointestinal bleeding) and the functional and
cognitive status of the resident 1 month before death.
The Bedford Alzheimer Nursing Severity Scale (BANS-
S) [12], the Global Deterioration Scale (GDS) stage 7
yes/no [13] and the Cognitive Performance Scale (CPS)
[14]were used. The GDS classifies dementia into 7 stages
based on cognition and function: Stage 7 is described as
very severe cognitive decline with minimal to no verbal
communication, assistance needed with toileting and
feeding, incontinence and loss of basic psychomotor
skills. The CPS assigns residents to cognitive perform-
ance categories, ranging from borderline intact to very
severe impairment.
The questionnaire for the treating physician included
questions on the presence of dementia and other dis-
eases at the time of death in the physician’s opinion (ma-
lignant cancer, severe cardiovascular disease,
cerebrovascular accident, severe pulmonary disease, se-
vere neurological disease, severe renal disease, severe
diabetes, other severe disease) and the presence of multi-
morbidity (counting the number of diseases at time of
death from the 8 diseases listed above).
Statistical analysis
All analyses were performed with SPSS 23. Preliminary
analyses included creating a variable for dementia that
does not underestimate its prevalence. When either the
physician or the nurse (or both) considered the resident
to have dementia, this was coded as ‘yes’. Stage of de-
mentia was based on the CPS and GDS scores, as an-
swered by nursing staff, after selecting residents with
dementia: CPS ≥ 5 and GDS =7 was classified as ‘very se-
vere or advanced dementia’, CPS ≥ 5 and GDS < 7 or
CPS ≤ 5 and GDS = 7 as ‘severe dementia’, CPS ≤ 5 and
GDS < 7 as ‘moderate or mild dementia’ [15].
All primary analyses had to account for the clustering
of the data (in countries, facilities and physicians or
nurses), thus a multilevel model was created for each
analysis. Depending on the outcome or target variable
(continuous, binary or categorical), generalized linear
mixed models were designed with a normal, binomial or
multinomial distribution. Country was included as a
fixed effect in each model in order to test for differences
between the 6 countries. The alpha level of α = 0.05 de-
fines statistical significance. Facility was included as a
random effect in each model. For variables that were
Table 1 Available types of facilities in six countries
Type 1 facilities with on-site physicians,
nurses and care assistants
Type 2 facilities with on-site nurses and
care assistants and off-site physicians
Type 3 facilities with on-site care assistants
and off-site nurses and physicians
Belgium X
The
Netherlands
X X
The United
Kingdom
X X
Finland X
Italy X X
Poland X X
Honinx et al. BMC Public Health         (2019) 19:1199 Page 3 of 12
based on questions answered by physicians or nursing
staff, either physician or nursing staff member was added
as a random effect. Significance of random effects are
not reported as this is not the main focus of this paper.
Because countries, except for Belgium and Finland,
had different facility types, we additionally conducted
multilevel models per country for each analysis with fa-
cility type used as a fixed effect.
Ethical aspects
The study protocol was approved by the relevant ethics
committee in 2015 in each country or waivers for the
collection of data of deceased residents were obtained
(the Netherlands and Italy). Participation was completely
anonymous and voluntary.
Results
In total in the 6 countries, 322 long-term care facilities
participated. Participating facilities identified 1707 resi-
dents who had died within the previous 3 months. Aver-
age response rates to the questionnaires for facility
manager/administrators were 95.7% (Belgium 94.2%, the
Netherlands 90.6%, England 96.4%, Finland 98.6%, Italy
96.5%, Poland 98.9%), for nursing staff 81.6% (Belgium
85.1%, the Netherlands 67.5%, England 54.2%, Finland
95.1%, Italy 91.7%, Poland 87.4%) and for treating physi-
cians 68.3% (Belgium 66.9%, the Netherlands 63.1%,
England 23.8%, Finland 80.2%, Italy 88.4%, Poland
75.6%). Figure 1 provides an overview of the total num-
bers of questionnaires in 6 countries that were distrib-
uted and returned per respondent. The final sample of
interest accounting for all missing information was 1384
deceased residents.
Non-response analysis
Using data provided by the facility administration, non-
response analysis showed no differences for important
demographic characteristics of the residents (age, sex,
length of stay, place of death) between participating and
non-participating nursing staff (data not shown). Be-
tween participating and non-participating physicians,
non-response analysis showed similar results except for
place of death (p = 0.04). The physicians more often
Fig. 1 Numbers of questionnaires (distributed and returned) regarding residents per respondent in 6 countries
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participated in cases where the resident died in the facil-
ity than when they died outside the facility.
Demographic and facility stay characteristics of dying
facility residents
The mean age of the residents at the time of death was
over 85 years except for those in Poland where it was 81
(Table 2). About 2/3 of the residents were female (63.5
to 75.0%) with no significant differences between coun-
tries. Most residents studied lived in a facility with on-
site care from nurses and care assistants but off-site care
from physicians. In the Netherlands and Poland how-
ever, most lived in a facility with on-site care from physi-
cians, nurses and care assistants (p < 0.001). The
facilities in which they lived also differed in size from an
average of 41 beds in Finland and England to 126 beds
in Belgium (p < 0.001). They also differed in type of own-
ership (p < 0.001); in most countries, the largest propor-
tion of residents lived in public non-profit facilities,
except for Italy and England where more stayed in pri-
vate for-profit facilities (41.8 and 86.8% respectively).
Most of the residents were admitted to the facility from
their own home (30.0 to 57.9%) and a large proportion
from a hospital (25.9 to 34.2%) except in the
Netherlands and Italy where fewer residents were admit-
ted from hospital (8.8% in the Netherlands and 16.8% in
Italy; p < 0.001). The median length of stay in the facility
ranged from less than 6 months in Poland to over 2 years
in Belgium (p = 0.025). At the time of death, most resi-
dents were not living in a ward or unit specifically de-
signed for residents with dementia. The largest
proportion of residents who did stay in a dementia ward
Table 2 Demographic and Facility Stay Characteristics of Dying Facility Residents in Six European countries: (N = 1384)
BE N = 291
N(%)
NL N = 222
N(%)
UK N = 91
N(%)
FI N = 269
N(%)
IT N = 200
N(%)
PL N = 311
N(%)
P-
value*
Age - yra
Mean (SD) years old at time of death 87 (7) 86 (9) 87 (9) 85 (9) 86 (8) 81 (11) < 0.001
Sexa
Female 174 (64.0) 132 (66.7) 66 (75.0) 169 (64.3) 136 (68.3) 195 (63.5) 0.387
Male 98 (36.0) 66 (33.3) 22 (25.0) 94 (35.7) 63 (31.7) 112 (36.5)
Type of ownership of facilitya
Public-nonprofit 135 (48.9) 211 (100.0) 2 (2.2) 211 (80.2) 66 (34.9) 201 (65.0) < 0.001
Private-nonprofit 124 (44.9) NA 10 (11.0) 24 (9.1) 44 (23.3) 104 (33.7)
Private-profit 17 (6.2) NA 79 (86.8) 28 (10.6) 79 (41.8) 4 (1.3)
Size of facilitya
Mean (SD) number of beds 126 (50) 124 (64) 41 (23) 41 (30) 101 (50) 72 (41) < 0.001
Residency before admission to facilitya
Own home (living alone or with family or
others)
100 (41.8) 99 (57.9) 43 (50.6) 77 (30.0) 95 (49.7) 153 (49.8) < 0.001
General hospital (e.g. acute care hospital) 76 (31.8) 15 (8.8) 22 (25.9) 85 (33.1) 32 (16.8) 105 (34.2)
Other facility 32 (13.4) 32 (18.7) 18 (21.2) 72 (28.0) 32 (16.8) 35 (11.4)
Other residency (e.g. psychiatric or
rehabilitation hospital)
31 (13.0) 14.6) 2 (2.4) 23 (8.9) 32 (16.8) 14 (4.6)
Length of staya
Median (min-max) number of days 745 (2–9706) 710 (1–6290) 600 (2–
4952)
581 (1–9218) 416 (2–10,
171)
145 (1–12,
365)
< 0.05
Type of ward at time of deatha
Ward for residents with dementia 104 (38.1) 94 (47.5) 29 (33.3) 115 (43.7) 74 (37.9) 56 (18.4) < 0.01
Ward not specifically for dementia 169 (61.9) 104 (52.5) 58 (66.7) 148 (56.3) 121 (62.1) 249 (81.6)
Place of Deatha
Facility 226 (82.2) 176 (89.3) 71 (81.6) 224 (84.8) 170 (86.7) 248 (80.0) 0.922
Other (e.g. hospital) 49 (17.8) 21 (10.7) 16 (18.4) 40 (15.2) 26 (13.3) 62 (20.0)
Missing values age = 13, sex = 13, type = 0, ownership = 6 size = 60, admission from = 145, length of stay = 36, type of ward dementia = 19, place of death = 11.
Percentages may not always add up to 100 because of rounding
*Generalised linear mixed model reporting p-value for country as a fixed effect, α = 0.05. Significant results in bold
aReported by administrator/manager of facility. For 44 out of 1384 residents no questionnaire was returned by the administrator/manager of facility; these are not
included as missing values below.
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was found in the Netherlands (47.5%) and the smallest
proportion in Poland (18.4%). Between 80% in of the res-
idents in Poland and 90% of the residents in the
Netherlands died in the facility and no significant differ-
ences were found between the countries regarding place
of death.
Clinical characteristics
In all 6 countries, more than 60% of the residents had
dementia at the time of death according to their treating
physician and/or nurse (Table 3). However, there was a
significant difference between countries (p < 0.001) with
the prevalence of dementia ranging from 60.2% in Eng-
land to 82.5% in Finland. Among residents who died
with dementia, no statistical difference between the
countries was found for the stage of dementia 1 month
before death. More than half of these had very severe or
advanced dementia shortly before death in Poland
(64.0%), Italy (55.0%) and Belgium (52.5%).
Other than dementia, the most prevalent disease at the
time of death was severe cardiovascular disease in all
countries (30.8–55.7% of residents) except England
(9.5%) (p < 0.001), where nearly half of the residents had
cancer (42.9%). For cerebrovascular accidents, severe
neurological disease, severe renal disease and severe dia-
betes no significant differences between countries were
found. Most of the residents had 2 or more morbidities
at the time of death (52.4 to 74.2%), except in the
Netherlands (47.3%), but no significant difference was
found between countries.
One month before death, residents in Italy and Poland
had the poorest functional and cognitive status (BANS-S
mean score of 21.8 and 21.9 respectively; p < 0.001)
(Table 3).
Clinical complications during the last month of life oc-
curred very often in residents in long-term care facilities
in all countries. These mostly consisted of eating or
drinking problems (51.9% England, 66.4% Finland and
Poland, no significant difference) (Table 3). The propor-
tion of people, according to the nurse, who had pneu-
monia during the last month of life varied between
21.2% in Poland and 37.7% in the Netherlands (p =
0.005). Febrile episodes other than pneumonia occurred
in the last month of life most often in Italy (52.4%).
Other clinical complications during the last month (hip
fracture, stroke, gastrointestinal bleeding and other) var-
ied between 24.2% in Finland and 41.8% in England (p =
0.013).
Differences between types of long-term care facilities
within countries
In England, we found no differences in resident charac-
teristics between types of facility. In Italy, having more
than 2 morbidities occurred more often in type 2
facilities (84,9%), no other differences were found.
Table 4 displays the differences between facility types for
the Netherlands and Poland.
In the Netherlands, type 1 facilities were larger than
type 2 facilities (mean 149 and 95 beds respectively; p =
0.031), they had a higher percentage of residents with
dementia (72.2 and 45.7% respectively; p = 0.004) and
poorer functional and cognitive status (p = 0.014). In
type 2 facilities, residents were more often admitted
from their own home (p = 0.013) and stayed less often in
a dementia ward (p = 0.017).
In Poland, type 1 facilities were smaller than type 2
(mean 56 and 104 beds respectively; p < 0.001), the
length of stay was considerably shorter (median length
of stay 60 and 1007 days respectively; p < 0.001) due to a
difference in admission criteria and the functional and
cognitive status of residents was poorer (BANS-S p <
0.001). Also, residents of type 1 facilities were more
often admitted from a hospital while those in type 2 fa-
cilities were more often admitted from their own home
(p < 0.001) and almost all residents died in the facility
(93.5%) while in type 2 facilities residents more often
had another place of death (39.7%) such as the hospital
(p < 0.001).
Discussion
We found that residents of long-term care facilities cur-
rently die at a very old age, on average around 85 years,
except in Poland where the mean age of death is 81. Be-
tween 80% of the residents in Poland and 90% of the res-
idents in the Netherlands die in the facility. A large
proportion of the residents (47–74%) have multiple co-
morbidities at the end of life and at least 60% have a
diagnosis of dementia, often at a very severe or advanced
stage. Clinical complications during the last month are
frequent and consist mainly of eating or drinking prob-
lems (51.9% England; 66.4% Finland and Poland). The
average length of stay is relatively short in all countries
and varies between 6months in Poland and Italy and 2
years in Belgium. The highest percentages of residents
with poor cognitive and functional status 1 month before
death are found in Poland and Italy, where residents also
have the shortest length of stay.
This study has several strengths. Firstly, it is the first
large-scale study to describe and compare demographic
and clinical characteristics of deceased residents of long-
term care facilities across 6 European countries. In Italy
and Poland this is the first time that nationally represen-
tative data have been collected in such facilities. We
were able to include 1384 people from 322 facilities in 6
countries, providing cross-country comparable data and
giving policy- and decision-makers insight into the key
international and national challenges facing the long-
term care facility population. Secondly, this study
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provides an excellent starting point for monitoring
changes over time. Thirdly, response rates from all
countries were high except in England and non-response
analysis shows minimal indication of bias. However, the
low numbers of residents included in England contribute
to statistical uncertainty for this country. Finally, the use
of different proxy respondents allowed for collection of
data for many characteristics of the same group of de-
ceased residents.
This study also has some limitations. Firstly, the risk
of highly achieving facilities or those with a special inter-
est in palliative care being more prone to participate
cannot be excluded. However, due to the proportional
stratified random sampling procedure, a nationally (or
Table 3 Clinical Characteristics of Dying Facility Residents in Six European Countries (N = 1384)
BE N = 291 NL N = 222 UK N = 91 FI N = 269 IT N = 200 PL N = 311
N(%) N(%) N(%) N(%) N(%) N(%) P-value*
Dementia at time of death (yes)abc 183 (62.9) 135 (61.4) 53 (60.2) 222 (82.5) 154 (77.0) 207 (67.9) < 0.001
Stage of Dementia (based on CPS/GDSd) ab
Moderate or mild dementia 27 (17.1) 29 (22.3) 13 (31.0) 43 (24.2) 14 (11.7) 17 (11.3) 0.676
Severe dementia 48 (30.4) 41 (31.5) 11 (26.2) 57 (32.0) 40 (33.3) 37 (24.7)
Very severe or advanced dementia 83 (52.5) 60 (46.2) 18 (42.9) 78 (43.8) 66 (55.0) 96 (64.0)
Diseases at time of deathbe
Malignant cancerb 30 (15.5) 27 (18.5) 9 (42.9) 41 (19.4) 26 (17.2) 10 (4.0) < 0.001
Severe cardiovascular diseaseb 67 (34.7) 45 (30.8) 2 (9.5) 79 (37.4) 71 (47.0) 141 (55.7) < 0.05
Cerebrovascular accident (CVA)b 40 (20.7) 25 (17.1) 3 (14.3) 49 (23.2) 34 (22.5) 70 (27.7) 0.483
Severe pulmonary diseaseb 33 (17.1) 17 (11.6) 3 (14.3) 17 (8.1) 40 (26.5) 18 (7.1) < 0.001
Severe neurological disease (not dementia)b 15 (7.8) 11 (7.5) 0 (0.0) 26 (12.3) 18 (11.9) 32 (12.6) 0.381
Severe renal diseaseb 19 (9.8) 19 (13.0) 2 (9.5) 13 (6.2) 22 (14.6) 29 (11.5) 0.420
Severe diabetesb 11 (5.7) 17 (11.6) 1 (4.8) 16 (7.6) 18 (11.9) 33 (13.0) 0.177
Other severe diseaseb 31 (16.1) 4 (2.7) 3 (14.3) 51 (24.2) 33 (21.9) 33 (13.0) < 0.001
Multimorbidities at time of deathb
0–1 long-term conditions 94 (48.7) 77 (52.7) 10 (47.6) 72 (34.1) 39 (25.8) 98 (38.7) 0.268
2 multimorbidities 54 (28.0) 40 (27.4) 8 (38.1) 68 (32.2) 52 (34.4) 102 (40.3)
3 multimorbidities 30 (15.5) 25 (17.1) 2 (9.5) 49 (23.2) 37 (24.5) 40 (15.8)
4 or more multimorbidities 15 (7.8) 4 (2.7) 1 (4.8) 22 (10.4) 23 (15.2) 13 (5.1)
Functional/cognitive status one month before death (BANS-S)af
Mean (SD) 18.5 (4.9) 17.7 (4.7) 17.5 (4.2) 19.6 (4.3) 21.8 (3.7) 21.9 (4.6) < 0.001
Cognitive Performance Scale one month before deathag
(Borderline) Intact (score 0–1) 75 (28.0) 42 (20.5) 17 (23.3) 23 (9.4) 16 (9.9) 72 (11.6) < 0.01
Mild to moderate impairment (score 2–3) 55 (20.5) 58 (28.2) 21 (28.7) 56 (22.9) 27 (16.7) 37 (15.9)
Moderately severe to very severe impairment (score 4–6) 138 (51.5) 105 (51.2) 35 (47.9) 165 (67.5) 118 (73.3) 169 (72.5)
Global Deterioration Scale Stage 7 one month before deathah 155 (57.8) 104 (47.5) 40 (50.6) 111 (48.3) 124 (66.0) 208 (73.2) < 0.001
Clinical complications during last month of lifea
Pneumoniaa 64 (24.2) 75 (37.7) 16 (21.6) 76 (31.4) 45 (25.3) 62 (21.2) < 0.01
Febrile episode (not pneumonia) a 118 (44.2) 36 (18.4) 4 (5.4) 78 (31.1) 98 (52.4) 136 (46.6) < 0.001
Eating or drinking problema 179 (65.3) 125 (60.4) 41 (51.9) 170 (66.4) 113 (60.8) 198 (66.4) 0.237
Other clinical complications (e.g. stroke)a 96 (33.0) 81 (36.5) 38 (41.8) 65 (24.2) 81 (36.5) 113 (36.3) < 0.05
Percentages may not always add up to 100 because of rounding
Missing values: dementia = 11, stage of dementia = 187 (419 not applicable because resident did not have dementia), diseases at time of death = 12,
multimorbidities = 12, BANS-S = 86 missing data on at least one item, CPS = 182 (and 18 not applicable), GDS7 = 116, clinical complications = 81
Abbreviations: CPS Cognitive Performance Scale, GDS Global Deterioration Scale, BANS-S Bedford Alzheimer Nursing Severity Scale
*Generalised linear mixed model reporting p-value for country as a fixed effect, α =0.05. Significant results in bold
aReported by staff member (nurse/care assistant) most involved in care
bReported by treating physician (TP) For 397 out of 1384 residents no questionnaire was returned by the TP, these are not included as missing values below
cWhen either the physician or the nurse (or both) considered the resident to have dementia, this was coded as yes
dThe variable stage of dementia was based on the scores on the CPS and GDS, as answered by nursing staff, after selecting residents with dementia [16]
eMultiple answers possible
fScores on BANS-S range from 7 to 28; higher scores indicate greater severity
gScores on CPS range from 0 to 6; higher scores indicate greater severity
hScores on GDS range from 0 to 6; higher scores indicate greater severity
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regionally in the UK and Belgium) representative sample
of long-term care facilities in terms of region/province
and facility size was achieved. Secondly, the possibility of
recall bias cannot be excluded because of the retrospect-
ive design of the study. As only deaths from the 3 previ-
ous months were included, memory bias is likely to be
minimal. Finally, it should be noted that our measure for
multimorbidity is based on a predefined list of severe
diseases, which explains why the proportion found in
our study is lower than in other studies [3].
We found that the large majority of residents of long-
term care facilities are female (Table 2). This is not a
surprising finding given that females generally live lon-
ger [17]. However, this is also likely a feature of them
having been widowed and alone for some time, having
no one left to care for them at home after their spouse
dies. With population ageing and people having to work
longer, it is likely that older women will increasingly die
in nursing homes, unless greater home support is
available.
The length of stay can be considered short in all 6
countries and is shorter now in Belgium and the UK
than it was a few years ago [16, 18](there are no trend
data available for the other countries). The length of stay
is particularly short in Poland and Italy where there is a
lower number of beds available in long-term care facil-
ities than in the other countries in our study [19], imply-
ing that potential residents have to wait longer to be
accommodated. Another reason for later admissions in
these countries might be the stronger tradition of infor-
mal instead of formal care [20, 21]. The short length of
stay found in this study confirms that long-term care fa-
cilities are more and more becoming places where
people go to live at the very end of their lives when they
are highly dependent and have complex health problems.
Policy in many countries indeed aims to keep older
people at home as long as possible i.e. until they reach
very high levels of disability [22]. Given the short length
of stay, almost all residents of these facilities can be con-
sidered to be at the end of life, making palliative care the
most appropriate care approach for this population. Pol-
icies supporting these facilities to integrate a palliative
care approach may bring substantial benefit to the
sector.
It is vital to recognize the complexity and intensity of
care that is required, especially in countries like Poland
and Italy. Not only is the median length of stay ex-
tremely short in these countries (as short as 60 days in
type 1 facilities in Poland), making the delivery of high
quality palliative and end-of-life care more challenging
[23], but we also found the highest levels of cognitive
and functional impairment as well as very high levels of
advanced dementia among the residents at the time of
death. At the same time, another study based on data
from the PACE project shows that palliative care know-
ledge among Polish and Italian nurses and care assis-
tants working in long-term care facilities is deficient
[24]. There is also evidence that the integration of pallia-
tive care in long-term care facilities in Poland and Italy
is minimal if not non-existent, especially compared with
countries like the UK, the Netherlands and Belgium [7].
National policies focusing on enhancing palliative care
development in long-term care facilities are particularly
needed in Poland and Italy to ensure optimal levels of
care.
The results of our study are in line with recent find-
ings in the literature on the rise of chronic diseases [25]
and increasingly complex care needs among residents of
long-term care facilities [26, 27]. We found that a large
proportion of residents have multiple morbidities, many
have considerable cognitive and functional impairment
in the last month of life (reflected in high levels of de-
pendency as shown by mean BANS-S scores ranging
from 17.5 in the UK to 21.9 in Poland), and at least 60%
die with dementia (Table 3). This has huge implications
for the care that they need. Caring for residents at the
end of life entails a high burden of care for the nurses
and care assistants working in this setting, and places ex-
tremely high demands on their knowledge, confidence
and skills in providing palliative care [28, 29]. The qual-
ity of care is thus highly contingent on staff and is a
major concern of long-term care facilities [30]. Giving
rising costs and demand, understanding how to meet the
increasingly complex needs of residents efficiently, and
determining and providing the appropriate numbers and
type of staff (skill mix) and the education and training in
palliative care that they need should be a high public
health priority. Inadequate skill mix in staff has been
linked to low-quality care [30]. Research therefore needs
to investigate which staff skills contribute to high-quality
palliative care. This study highlighted various complex
health problems of nursing home residents (dementia,
comorbidities, eating and drinking problems and poor
cognitive and functional status). Education of nursing
staff should focus on learning skills to handle these
health problems. Finally, given that so many residents
suffer from advanced dementia at the time of death, we
also recommend that policies addressing this sector
highlight the need for the integration of high-quality pal-
liative care together with high-quality dementia care, en-
abling long-term care facilities to become centers of
excellence in dementia end-of-life care.
Conclusion
Although there are important country differences, the
population currently living and dying in long-term care
facilities is very complex, displaying multiple diseases
with considerable cognitive and functional impairment
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and high levels of dementia. Given the complex care
needs of long-term care facility residents, palliative care
is the most appropriate care approach for this popula-
tion and education of nursing staff should include learn-
ing skills to meet these needs. Since many residents also
suffer from advanced dementia at the time of death, we
recommend that policies addressing this sector highlight
the need for the integration of high-quality palliative
care together with high-quality dementia care. This
study is an excellent starting point for monitoring popu-
lations of people who die in long-term care facilities.
The current challenges of dying in such facilities need
adequate policy and practice responses as soon as
possible.
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